Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Qinghai Spring Medicinal Resources Technology Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥4.99 |
52 Week High | CN¥10.09 |
52 Week Low | CN¥4.55 |
Beta | 0.53 |
1 Month Change | -16.97% |
3 Month Change | -35.28% |
1 Year Change | -45.58% |
3 Year Change | -19.39% |
5 Year Change | -38.24% |
Change since IPO | -82.62% |
Recent News & Updates
Shareholder Returns
600381 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -14.6% | -3.4% | -2.2% |
1Y | -45.6% | -11.4% | -14.8% |
Return vs Industry: 600381 underperformed the CN Pharmaceuticals industry which returned -11.4% over the past year.
Return vs Market: 600381 underperformed the CN Market which returned -14.8% over the past year.
Price Volatility
600381 volatility | |
---|---|
600381 Average Weekly Movement | 9.6% |
Pharmaceuticals Industry Average Movement | 6.9% |
Market Average Movement | 8.1% |
10% most volatile stocks in CN Market | 11.4% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 600381's share price has been volatile over the past 3 months.
Volatility Over Time: 600381's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 175 | Xuefeng Zhang | https://www.verygrass.com |
Qinghai Spring Medicinal Resources Technology Co., Ltd. research and development, production, and sale of cordyceps products. It is also involved in the sale of beverages and aquatic products; advertising; and foreign investment business.
Qinghai Spring Medicinal Resources Technology Co., Ltd. Fundamentals Summary
600381 fundamental statistics | |
---|---|
Market cap | CN¥3.11b |
Earnings (TTM) | -CN¥282.48m |
Revenue (TTM) | CN¥192.24m |
15.2x
P/S Ratio-10.4x
P/E RatioIs 600381 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600381 income statement (TTM) | |
---|---|
Revenue | CN¥192.24m |
Cost of Revenue | CN¥143.04m |
Gross Profit | CN¥49.21m |
Other Expenses | CN¥331.68m |
Earnings | -CN¥282.48m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 24, 2024
Earnings per share (EPS) | -0.48 |
Gross Margin | 25.60% |
Net Profit Margin | -146.94% |
Debt/Equity Ratio | 0% |
How did 600381 perform over the long term?
See historical performance and comparison